Skip to main content
Boen Group CO., LTD. logo

Boen Group CO., LTD. — Investor Relations & Filings

Ticker · 001366 ISIN · CNE1000061K1 LEI · 836800TDBUJJ7BFFRT62 Shenzhen Stock Exchange Agriculture, forestry and fishing
Open in API
Filings indexed 461 across all filing types
Latest filing 2025-04-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 001366

About Boen Group CO., LTD.

https://www.bo-en.com

Boen Group CO., LTD. operates as an integrated enterprise focusing on animal nutrition, livestock breeding, and food processing. The company specializes in the research, development, and production of high-quality animal feed, premixes, and veterinary medicines. Its core operations encompass large-scale poultry and swine breeding, utilizing advanced biotechnology and modern management systems to optimize production efficiency. Boen Group manages a comprehensive supply chain that extends from raw material sourcing and feed manufacturing to standardized farming and the distribution of processed meat products. By prioritizing technological innovation and food safety, the company provides end-to-end solutions for the livestock sector, including genetic improvement programs and animal health management services.

Recent filings

Filing Released Lang Actions
关于2025年第一季度计提减值的公告
Regulatory Filings Classification · 90% confidence The document is an announcement regarding the company's asset impairment provision for the first quarter of 2025. It details the impairment amounts for various asset categories such as inventory, accounts receivable, and other receivables, including the accounting policies and methods used for impairment testing. The document explicitly states the impairment provision affects the financial results for the quarter ending March 31, 2025, and mentions it is unaudited. The document length is 2761 characters, which is relatively short but contains substantive financial data and detailed explanations of impairment accounting. It is not a full quarterly report but a specific impairment provision announcement. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure about impairment provisions rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K). It is not a simple announcement of a report publication (RPA) because it contains detailed financial data and accounting policy explanations. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2025-04-27 Chinese
关于股东股份减持计划期限届满的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the expiration of a shareholder stock reduction plan, detailing the number of shares reduced, the methods of reduction, and the shareholders involved. It references compliance with securities laws and stock exchange rules, and provides specific data on shareholding changes before and after the reduction. There is no indication that this is a financial report, earnings release, or management discussion. Instead, it is a regulatory announcement about shareholders' transactions in their own shares. This fits the category of 'Transaction in Own Shares' (POS). The document length is about 3,134 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is POS with high confidence.
2025-03-19 Chinese
海通证券关于播恩集团继续使用部分闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from Haitong Securities regarding the continued use of idle raised funds by Boen Group for cash management. It references regulatory guidelines on the management and use of raised funds, details the amount and purpose of the raised funds, the investment projects, and the risk control measures for cash management. It includes approvals from the board and supervisory committee and the sponsor's verification opinion. The document is not a full annual or interim financial report, nor is it an earnings release or a proxy statement. It is a regulatory compliance and verification report related to the use of raised funds, which fits best under Regulatory Filings (RNS) as it does not constitute a standalone audit report or a capital/financing update but is a regulatory disclosure about fund usage and compliance.
2025-03-14 Chinese
第三届监事会第十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of the company regarding decisions made in their meeting. It includes voting results on proposals related to the use of idle raised funds, cash management, and project delays. The document is an official announcement of meeting resolutions rather than a full report or detailed financial data. It does not contain financial statements or detailed management discussion. The document length is short (1650 characters), and it serves as a formal disclosure of board decisions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2025-03-14 Chinese
关于投资建设播恩生物产业园项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's investment in a new biological industrial park project. It details the project scope, investment amount, board approval, and risk factors. It does not contain financial statements or detailed financial performance data. The document is relatively short (1957 characters) and serves as a formal disclosure of a capital investment decision. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes related to investments.
2025-03-14 Chinese
海通证券关于播恩集团闲置募集资金暂时补充流动资金的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from Haitong Securities regarding the use of part of idle raised funds by Boen Group Co., Ltd. to temporarily supplement working capital. It references regulatory guidelines on the management and use of raised funds, details the amount of funds raised, their intended use, and the company's board and supervisory approvals for the temporary use of idle funds. The document includes specific financial figures related to the raised funds and their usage, as well as the approval process and compliance with relevant regulations. It is not an announcement of a report publication, nor a certification letter. It is a regulatory compliance and verification report related to the use of raised funds, which fits best under Regulatory Filings (RNS) as it does not constitute a full financial report, earnings release, or capital update but is a regulatory disclosure about fund usage and compliance.
2025-03-14 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.